Letter by Aw et al Regarding Article, "Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention" [Letter to the Editor]
Source: Circulation: Cardiovascular Genetics - Category: Cardiology Authors: Aw, J. W. X., Tan, D. S.-Y., Goh, L. L. Tags: Genetics, Percutaneous Coronary Intervention, Acute Coronary Syndromes Letter to the Editor Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Coronary Angioplasty | Genetics | Heart | Percutaneous Coronary Intervention